NYSE:AVTRAvantor Stock Price, Forecast & News

Avantor's stock was trading at $12.92 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AVTR stock has increased by 41.4% and is now trading at $18.27. View which stocks have been most impacted by Coronavirus.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 4 hold ratings and 20 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Avantor.

Avantor is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Avantor.

Avantor Inc (NYSE:AVTR) released its quarterly earnings data on Wednesday, April, 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.15 by $0.02. The business had revenue of $1.52 billion for the quarter, compared to analysts' expectations of $1.45 billion. Avantor's revenue was up 2.6% on a year-over-year basis. During the same period last year, the firm posted $0.11 earnings per share. View Avantor's earnings history.

24 brokerages have issued 12 month price objectives for Avantor's stock. Their forecasts range from $15.00 to $23.00. On average, they anticipate Avantor's share price to reach $19.94 in the next year. This suggests a possible upside of 9.1% from the stock's current price. View analysts' price targets for Avantor.

Headlines about AVTR stock have trended somewhat negative recently, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Avantor earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future. View the latest news aboutAvantor.

Avantor saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 8,640,000 shares, an increase of 6.7% from the April 30th total of 8,100,000 shares. Based on an average trading volume of 3,110,000 shares, the short-interest ratio is currently 2.8 days. Approximately 1.6% of the shares of the company are sold short. View Avantor's Current Options Chain.

Some companies that are related to Avantor include Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Waters (WAT), PerkinElmer (PKI), Bruker (BRKR), Coherent (COHR), Quanterix (QTRX), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO) and HTG Molecular Diagnostics (HTGM). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Eastman Chemical (EMN), Alibaba Group (BABA), Home Depot (HD), Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), CVS Health (CVS), Honeywell International (HON), Abbott Laboratories (ABT) and Cisco Systems (CSCO).

(AVTR) raised $3 billion in an initial public offering on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

Avantor's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Nuveen Asset Management LLC (3.05%), Viking Global Investors LP (1.75%), Eminence Capital LP (1.03%), Maverick Capital Ltd. (0.98%), Third Point LLC (0.87%) and New South Capital Management Inc. (0.53%). Company insiders that own Avantor stock include Devashish Ohri, Gerard Brophy, Jo Natauri, Michael Wondrasch and New Mountain Investments Iii,. View institutional ownership trends for Avantor.

AVTR stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Third Point LLC, Jennison Associates LLC, Mackay Shields LLC, Wells Fargo & Company MN, Balyasny Asset Management LLC, Loomis Sayles & Co. L P, and First Trust Advisors LP. Company insiders that have sold Avantor company stock in the last year include Devashish Ohri, Gerard Brophy, Jo Natauri, Michael Wondrasch, and New Mountain Investments Iii,. View insider buying and selling activity for Avantor.

AVTR stock was bought by a variety of institutional investors in the last quarter, including Eminence Capital LP, New South Capital Management Inc., Country Trust Bank, Maverick Capital Ltd., Viking Global Investors LP, Peregrine Capital Management LLC, Obermeyer Wood Investment Counsel Lllp, and New York State Common Retirement Fund. View insider buying and selling activity for Avantor.

Shares of AVTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVTR stock can currently be purchased for approximately $18.27.

Avantor has a market capitalization of $10.50 billion and generates $6.04 billion in revenue each year. Avantor employs 12,000 workers across the globe.

The official website for Avantor is www.avantorsciences.com.

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The company can be reached via phone at 610-386-1700 or via email at [email protected]